Antipodean Advisors LLC - Q3 2019 holdings

$120 Million is the total value of Antipodean Advisors LLC's 12 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 100.0% .

 Value Shares↓ Weighting
RPLA ExitREPLAY ACQUISITION CORP$0-15,500
-100.0%
-0.19%
EXAS ExitEXACT SCIENCES CORP$0-3,000
-100.0%
-0.43%
LYFT ExitLYFT INC$0-21,000
-100.0%
-1.68%
CMCSA ExitCOMCAST CORP NEWcl a$0-95,000
-100.0%
-4.89%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CARVANA CO21Q2 202338.5%
AMAZON COM INC20Q4 202033.8%
SEA LTD19Q3 202360.8%
CARDLYTICS INC18Q3 202326.3%
MEDICINES CO18Q4 201919.8%
ATARA BIOTHERAPEUTICS INC15Q3 202317.9%
CONSTELLATION BRANDS INC14Q4 201611.1%
HERBALIFE NUTRITION LTD13Q1 202124.8%
CLARIVATE PLC11Q4 202124.4%
EXACT SCIENCES CORP11Q2 201924.6%

View Antipodean Advisors LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Antipodean Advisors LLC Q3 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Oncothyreon Inc.Sold outJanuary 09, 201300.0%

View Antipodean Advisors LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15
13F-HR2021-08-16

View Antipodean Advisors LLC's complete filings history.

Compare quarters

Export Antipodean Advisors LLC's holdings